Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S P Richman

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1983
Combination chemotherapy with cis-diamminedichloroplatinum and vinblastine in advanced non-small cell lung cancerT M Woodcock, M S Blumenreich, S P Richman, et al.
Cancer Treatment Reports|November 1, 1984
Phase II trial of vinblastine, bleomycin, and cisplatin (VBP) followed by dacarbazine and mitolactol in metastatic melanomaS P Richman, T M Woodcock, T T Kubota, et al.
Cancer|October 1, 1994
Phase I trial of low dose N-phosphonacetyl-L-aspartic acid and high dose 5-fluorouracil administered concomitantly with radiation therapy for unresectable localized adenocarcinoma of the pancreasB Ardalan, A Ucar, R Reddy, et al.
Melanoma Research|August 1, 1995
Phase II trial of recombinant interferon-alpha with BCNU, cisplatin, DTIC and tamoxifen in advanced malignant melanomaL G Feun, N Savaraj, F Moffat, et al.
Cancer Treatment Reports|May 1, 1981
Administration of BCG cell wall skeleton into malignant effusions: toxic and therapeutic effectsS P Richman, E M Hersh, J U Gutterman, et al.
Cancer|March 1, 1985
High-dose cisplatin in patients with advanced malignanciesM S Blumenreich, T M Woodcock, M Jones, et al.
Cancer|July 15, 1985
A phase I trial of dactinomycin intravenous infusion in patients with advanced malignanciesM S Blumenreich, T M Woodcock, S P Richman, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1995
A phase II trial of continuous-infusion recombinant interleukin-2 in patients with advanced renal cell carcinoma: a Southwest Oncology Group studyR P Whitehead, M K Wolf, D L Solanki, et al.
Seminars in Oncology|December 1, 1984
Pharmacology and phase I clinical studies of daunorubicin in patients with advanced malignanciesT M Woodcock, J C Allegra, S P Richman, et al.
American Journal of Clinical Oncology|August 1, 1991
Phase II trial of mitoxantrone in head and neck carcinomaK S Sridhar, A M Hussein, P Benedetto, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1983
Combination chemotherapy with cis-diamminedichloroplatinum and vinblastine in advanced non-small cell lung cancerT M Woodcock, M S Blumenreich, S P Richman, et al.
Cancer Treatment Reports|November 1, 1984
Phase II trial of vinblastine, bleomycin, and cisplatin (VBP) followed by dacarbazine and mitolactol in metastatic melanomaS P Richman, T M Woodcock, T T Kubota, et al.
Cancer|October 1, 1994
Phase I trial of low dose N-phosphonacetyl-L-aspartic acid and high dose 5-fluorouracil administered concomitantly with radiation therapy for unresectable localized adenocarcinoma of the pancreasB Ardalan, A Ucar, R Reddy, et al.
Melanoma Research|August 1, 1995
Phase II trial of recombinant interferon-alpha with BCNU, cisplatin, DTIC and tamoxifen in advanced malignant melanomaL G Feun, N Savaraj, F Moffat, et al.
Cancer Treatment Reports|May 1, 1981
Administration of BCG cell wall skeleton into malignant effusions: toxic and therapeutic effectsS P Richman, E M Hersh, J U Gutterman, et al.
Cancer|March 1, 1985
High-dose cisplatin in patients with advanced malignanciesM S Blumenreich, T M Woodcock, M Jones, et al.
Cancer|July 15, 1985
A phase I trial of dactinomycin intravenous infusion in patients with advanced malignanciesM S Blumenreich, T M Woodcock, S P Richman, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1995
A phase II trial of continuous-infusion recombinant interleukin-2 in patients with advanced renal cell carcinoma: a Southwest Oncology Group studyR P Whitehead, M K Wolf, D L Solanki, et al.
Seminars in Oncology|December 1, 1984
Pharmacology and phase I clinical studies of daunorubicin in patients with advanced malignanciesT M Woodcock, J C Allegra, S P Richman, et al.
American Journal of Clinical Oncology|August 1, 1991
Phase II trial of mitoxantrone in head and neck carcinomaK S Sridhar, A M Hussein, P Benedetto, et al.
Pageof 5